SensiGen is a development stage biotechnology company focused on gene-based molecular diagnostics. Its mission is to enable early detection of disease and prevent unnecessary suffering and financial burden. The Company is commercializing a revolutionary technology platform capable of unprecedented sensitivity and specificity which can be broadly applied to many diseases and conditions including cancer and infectious diseases.
 
 


About Us  |   Management Team  |   Scientific Advisory Board  |   Technology Overview  |   News  |   Contact Us
© Copyright 2006. SensiGen, LLC. All Rights Reserved.